HIV Integrase Inhibitor Pharmacogenetics and Clinical Outcomes, An Exploratory Association Study

Normal Human Plasma from Innovative Research was recently used in the following study:

HIV Integrase Inhibitor Pharmacogenetics and Clinical Outcomes: An Exploratory Association Study

Derek E. Murrell
East Tennessee State University Digital Commons, August 2018

"...Briefly, a standard curve ranging from 10 ng/mL to 1,500 ng/mL was created for drugs of interest from respective stock solutions in a 50:50 ratio of acetonitrile and water, using blank human plasma (Innovative Research Inc Novi, MI). Verapamil, a drug which no subject was concurrently receiving, was used as the internal standard in acetonitrile and 1% formic acid in water (80:20)..."

Related products available from Innovative Research also include: